We are live on ! Find out more
SIM

Stelliam Investment Management Portfolio holdings

AUM $404M
1-Year Est. Return 5.1%
This Fund
S&P 500
This Quarter Est. Return
+16.12%
1 Year Est. Return
-5.1%
3 Year Est. Return
+21.26%
5 Year Est. Return
+17.69%
10 Year Est. Return
AUM
$2.45B
AUM Growth
+$353M
Cap. Flow
+$82.4M
Cap. Flow %
3.36%
Top 10 Hldgs %
33.08%
Holding
60
New
8
Increased
29
Reduced
13
Closed
10

Top Buys

Rank Stock Value
1
AMGN icon
Amgen
AMGN
+$45.5M
2
C icon
Citigroup
C
+$41.6M
3
MON
Monsanto Co
MON
+$38.2M
4
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
+$35.4M
5
CHE icon
Chemed
CHE
+$28.2M

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceuticals
TEVA
+$69.4M
2
COF icon
Capital One
COF
+$48.1M
3
SNDK
SANDISK CORP
SNDK
+$26.3M
4
LPX icon
Louisiana-Pacific
LPX
+$24.3M
5
STX icon
Seagate
STX
+$19.8M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 19.46%
2 Technology 17.35%
3 Industrials 13.76%
4 Energy 12.86%
5 Financials 11.75%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PFE icon
26
Pfizer
PFE
$154B
$43M 1.75%
1,480,870
-276,675
-16% -$8.05M
C icon
27
Citigroup
C
$227B
$42.9M 1.75%
+822,500
New +$41.6M
TOL icon
28
Toll Brothers
TOL
$14B
$42.7M 1.74%
1,155,000
+230,000
+25% +$7.63M
PBF icon
29
PBF Energy
PBF
$7.86B
$42M 1.71%
1,335,000
-526,000
-28% -$14.4M
GT icon
30
Goodyear
GT
$1.74B
$41.9M 1.71%
1,757,500
+610,000
+53% +$13.5M
RRC icon
31
Range Resources
RRC
$9.41B
$41.3M 1.68%
490,000
+77,500
+19% +$6.03M
MON
32
DELISTED
Monsanto Co
MON
$40.8M 1.66%
+350,000
New +$38.2M
CE icon
33
Celanese
CE
$4.88B
$40.5M 1.65%
732,500
+42,500
+6% +$2.36M
ELV icon
34
Elevance Health
ELV
$86.2B
$40.1M 1.63%
434,000
-86,000
-17% -$7.64M
GWR
35
DELISTED
Genesee & Wyoming Inc.
GWR
$39.5M 1.61%
411,500
+123,000
+43% +$11.9M
TYC
36
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
$39.1M 1.59%
+909,637
New +$35.4M
ODFL icon
37
Old Dominion Freight Line
ODFL
$44.1B
$38.3M 1.56%
2,167,500
+225,000
+12% +$3.69M
WDC icon
38
Western Digital
WDC
$151B
$36.9M 1.51%
582,120
-148,838
-20% -$8.32M
APC
39
DELISTED
Anadarko Petroleum
APC
$36.7M 1.5%
462,500
+142,500
+45% +$12.8M
USB icon
40
US Bancorp
USB
$100B
$35.2M 1.44%
872,500
+97,500
+13% +$3.74M
SJI
41
DELISTED
South Jersey Industries, Inc.
SJI
$35M 1.43%
1,250,000
+310,000
+33% +$8.86M
NVDA icon
42
NVIDIA
NVDA
$5.27T
$34.6M 1.41%
86,400,000
+12,400,000
+17% +$4.8M
KND
43
DELISTED
Kindred Healthcare
KND
$33.7M 1.37%
1,707,500
-21,900
-1% -$353K
SNDK
44
DELISTED
SANDISK CORP
SNDK
$33.3M 1.36%
472,500
-390,000
-45% -$26.3M
RF icon
45
Regions Financial
RF
$26.8B
$33.3M 1.36%
3,365,000
+497,500
+17% +$4.79M
BERY
46
DELISTED
Berry Global Group, Inc.
BERY
$32.3M 1.32%
1,478,318
+215,078
+17% +$4.09M
CHE icon
47
Chemed
CHE
$7.18B
$29.3M 1.19%
+382,500
New +$28.2M
LOGI icon
48
Logitech
LOGI
$15B
$19.1M 0.78%
1,397,500
+662,500
+90% +$7.2M
LEN icon
49
Lennar Class A
LEN
$20.6B
$15.8M 0.65%
+420,224
New +$14.2M
STAY
50
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
$9.19M 0.37%
+350,000
New +$8.63M

Similar funds

Stelliam Investment Management's Q4 2013 Portfolio in Review

As of Q4 2013, Stelliam Investment Management held 60 positions worth $2.45B, up 17% from $2.1B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Stelliam Investment Management deployed $82.4M of net new capital in Q4 2013, opening 8 new positions and adding to 29 existing holdings. Its largest new stake was Amgen: 400,000 shares worth $45.7M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 17% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was SANDISK CORP, an estimated $26.3M trimmed.

  • Stelliam Investment Management's largest Q4 2013 buy was Amgen: 400,000 shares worth $45.7M.
  • Stelliam Investment Management added most to GameStop in Q4 2013, an estimated $19.7M increase.
  • Stelliam Investment Management's biggest Q4 2013 reduction was SANDISK CORP, cutting an estimated $26.3M.
  • Stelliam Investment Management fully exited Teva Pharmaceuticals in Q4 2013, selling an estimated $69.4M.
  • Stelliam Investment Management's ten largest holdings make up 33% of its $2.45B portfolio in Q4 2013.
  • Stelliam Investment Management opened 8 new positions and closed 10 in Q4 2013.
  • Stelliam Investment Management's portfolio value rose 17% quarter-over-quarter to $2.45B.

Based on Stelliam Investment Management's 13F filing for Q4 2013, filed 14 Feb 2014.